APIS Assay Technologies is leveraging the transformational power of systems biology and big data to directly address the historical failures of translating biomarkers into clinical utility.By linking genomic biomarker research and clinical history...
MGME Neurotech provides neurobiological assessment and training solutions to combat the devastating effects of stress-related productivity loss, burnout, and turnover in the workplace.
ApiniLabs will enable post-monolytic lab software by providing smart building blocks.
Aqsens Health is a Finnish biotech startup developing non-invasive screening tests for high-impact diseases. The company’s patented E-TRF method and biosensors provide new means for disease detection and biomarker discovery.
BatchX is a unique platform that offers a no-code solution for bioinformatics analysis and also serves as a marketplace.
Bioeureka's technology allows laboratory professionals and microbiologists to obtain results faster while being more efficient in their work.
BioFi’s proprietary virtual twin technology CellSim™ is a novel way to virtually engage and experiment with cell biology, to accelerate your research and optimize your products and processes.
We are a pioneer in AI mediated proximity inducing compound (PIC) engineering. We use cutting edge computational tools in conjunction with lab automation to tackle hard to drug diseases.
The startup droptical develops innovative dispensers for volumes in the range between 0.2 nl and 25.0 nl and camera systems for continuous process monitoring of almost all jet dispensing systems.
Arachne.ai is a biomedical data engine enabling ML/AI methods in drug discovery, allowing researchers to get ready-to-go datasets in a single line of code.
Spatial biology is the next frontier in life sciences and beyond. This pioneering field enables the study of the precise cellular architecture of tissues and organs, how cells communicate and cooperate to execute tissue functions, as well as organ...
Best in class ophthalmic diagnostic system validated in a clinical trial. Can diagnose more eye diseases than competitors and supports multimodal diagnosis.
We are developing an AI Assistant that is able to interact with healthcare legacy systems and take care of the everyday, time-consuming tasks to save hospital staff time and allow them to focus on patients
Hedera Dx is on a mission to simplify cancer testing globally and aims at transforming oncology by enabling routine use of liquid biopsies, one of the most transformational innovations in cancer care for the next decade.
iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development, to build a digital library of biomarkers and biological profiles.
At inSEIT, we work to remove the barriers that hamper the commercialization of immobilized enzymes and their integration in industrial conditions using our novel bioinformatic tools.
Iron Bridge is a contract research organization (CRO) that provides comprehensive support for clinical trials. Our core expertise lies in enabling efficient clinical trials in the fields of oncology and personalized medicine with the goal of...
At InkVivo we combine our biomaterial platform with advanced manufacturing approaches to fabricate novel drug delivery systems that ensure temporal controlled release of active ingredients.
Kairntech democratizes the way businesses transform text into actionable information: accessible to all, fast, accurate and fun to use. Build NLP pipelines and embed these within business applications.
KML Vision's IKOSA Platform equips life science researchers with a no-code solution using advanced AI for specialized bioimage analysis, delivering precise and reproducible results.
We take the pain out of AI and Data Science with solutions we design and services we offer. Our T2R2, is the sole Platform that is Transparent, Traceable, Replicable and Reproducible (T2R2) by design.
mo:re is reducing the time to market for new therapies by replacing animal trials with AI-assisted cultivation of disease models, scaling up experiments without compromising traceability and quality.
Nemosia AG develops Positron Emission Tomography (PET) tracers targeting the NMDA receptor. Our tracers can provide early detection for neurodegenerative diseases such as Alzheimer's disease.
Neobe is a UK based early-stage startup aiming to enable immunotherapy efficacy in non-responsive cancer patients through programmable live biotherapeutics, engineered to remove barriers to immune infiltration in solid tumours.
Our mission is to ensure the best possible outcome for patients by providing cancer-specific molecular diagnostic tests and monitoring solutions with a clear focus on actionable hot spot mutations.
Plovr is a software company providing an operating system for aftersales of lab hardware: we digitize the service processes and support brands in maintaining a consistently positive customer relationship
Popit makes medication connected with a unique solution, so patients get better treatment outcomes. Our certified platform increases adherence & engagement,and the customers include world’s largest pharma companies.
GPT-4 of Radiology: Raidium is a Medtech startup developing the first ever radiological foundation model to tackle the complexity of precision medicine.
Rapid Fluidics provides microfluidic design, prototyping and manufacturing services using a novel approach to rapidly and accurately produce microfluidic test cards.
The scopeDx® CRISPR based molecular detection platform offers on-site DNA or RNA identification with incredible sensitivity and specificity, for use in diagnostics and genotyping applications.
ShanX Medtech is a young, Dutch company developing novel antibiotic efficiency testing devices for the point of need.
SoftMining is an AI-powered drug discovery company that designs new molecules for therapeutics. Our mission is to generate new molecules to address medical needs.
Symposium Lab is building Bloomberg for Scientific Research. We empower scientific research by helping scientists and institutions automate data processing, integration, and analytics.
A sensitive HIV-1 nucleic acid quantification assay has been developed, patented, and published (Kibirige et al. Sci Reps 2022). It has been validated according to US FDA guidelines for viral load assays and shown to have broad cross-subtype...
UNOMR is a BioTech ETH spin-off that provides a patented, next-generation serial nanopore-sensor for single-molecule protein analysis and sequencing. We envision true personalized medicine based on proteomics.